Literature DB >> 19543246

Papillary carcinoma of the breast lacks evidence of RET rearrangements despite morphological similarities to papillary thyroid carcinoma.

Omar Hameed1, Arie Perry, Ruma Banerjee, Xiaopei Zhu, John D Pfeifer.   

Abstract

Rare breast neoplasms resembling the tall-cell variant of papillary thyroid carcinoma have been reported. In addition, papillary carcinoma of the breast occasionally displays nuclear features reminiscent of papillary thyroid carcinoma. In this study, we evaluated 33 intraductal/intracystic papillary carcinomas of the breast for the presence and extent of nuclear overlap, grooves, clearing, and inclusions, as well as features of the tall-cell or columnar-cell variants of papillary thyroid carcinoma. RET rearrangements were assessed in a subset of these cases. Paired probes localizing to the centromeric and telomeric ends of the RET gene on chromosome 10 were used for FISH using a break-apart approach. Single round and nested PCR was performed to detect RET/PTC1, RET/PTC2, RET/PTC3 and ELKS-RET fusion transcripts. Nuclear overlap, grooves, stratification, and clearing were identified in 24 (73%), 14 (42%), 11 (33%), and 9 (27%) cases respectively, whereas nuclear inclusions and 'tall-cell' features were each seen in only one (3%) and two (6%) cases, respectively. Four of 19 tested cases displayed split FISH signals in a low percentage of cells and were considered borderline for RET rearrangement. All 19 tested cases with amplifiable RNA were negative for the four RET fusion transcripts evaluated by RT-PCR. Although papillary carcinomas of breast often display one or more cytoarchitectural features of papillary thyroid carcinoma, there is no evidence that RET rearrangements are involved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19543246     DOI: 10.1038/modpathol.2009.91

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  4 in total

1.  Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review.

Authors:  Yufan Wei; Liming Ding; Xin Song; Xia Tian; Ningning Min; Qingyu Guan; Xiru Li; Mei Liu
Journal:  Gland Surg       Date:  2021-11

2.  Tall cell carcinoma of the breast with reverse polarity: case report with gene sequencing and literature review.

Authors:  Xiaohui Zhang; Huanwen Wu; Zhe Wang; Yidong Zhou; Feng Mao; Yan Lin; Songjie Shen; Zhiyong Liang; Qiang Sun
Journal:  Gland Surg       Date:  2021-02

3.  IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity.

Authors:  Sarah Chiang; Britta Weigelt; Huei-Chi Wen; Fresia Pareja; Ashwini Raghavendra; Luciano G Martelotto; Kathleen A Burke; Thais Basili; Anqi Li; Felipe C Geyer; Salvatore Piscuoglio; Charlotte K Y Ng; Achim A Jungbluth; Jörg Balss; Stefan Pusch; Gabrielle M Baker; Kimberly S Cole; Andreas von Deimling; Julie M Batten; Jonathan D Marotti; Hwei-Choo Soh; Benjamin L McCalip; Jonathan Serrano; Raymond S Lim; Kalliopi P Siziopikou; Song Lu; Xiaolong Liu; Tarek Hammour; Edi Brogi; Matija Snuderl; A John Iafrate; Jorge S Reis-Filho; Stuart J Schnitt
Journal:  Cancer Res       Date:  2016-10-20       Impact factor: 13.312

4.  Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.

Authors:  John R Lozada; Thais Basili; Fresia Pareja; Barbara Alemar; Arnaud Da Cruz Paula; Rodrigo Gularte-Merida; Dilip D Giri; Patricia Querzoli; Gabor Cserni; Emad A Rakha; Maria P Foschini; Jorge S Reis-Filho; Edi Brogi; Britta Weigelt; Felipe C Geyer
Journal:  Histopathology       Date:  2018-06-01       Impact factor: 7.778

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.